Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Mccourt Marion
Relationship:   EVP Commercial
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   12,931    

Indirect Shares

  174      
Direct Value   $12,737,294    

Indirect Value

  $171,393      
Total Shares   13,105      
Total Value   $12,908,687      


Regeneron Pharmaceuticals Inc
 $12,737,294 Regeneron Pharmaceuticals Inc
 $12,737,294
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    4    

     Stock price went up :

    0   
    4    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   4.0   
     Percentage Gain/Loss :
     0.0%
 31.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Medivation Inc MDVN Chief Operating Officer 2016-09-28 0 2016-02-03 0    Premium*  
            Regeneron Pharmaceuticals Inc REGN EVP Commercial 2024-05-01 12,931 2024-05-01 174    Premium*  
* Premium Members only  

Records found :    87         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2023-11-01 4 AS $783.91 $783,910 D/D (1,000) 19,803 0 %
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2023-12-08 4 A $0.00 $0 D/D 2,133 21,084 0 -
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2023-12-08 4 D $843.79 $718,909 D/D (852) 18,951 0 -
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2023-12-11 4 AS $838.44 $226,379 D/D (270) 20,814 0 %
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2023-12-11 4 D $844.09 $314,846 D/D (373) 20,441 0 -
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2023-12-12 4 D $856.71 $4,373,505 D/D (5,105) 15,336 0 -
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2024-01-02 4 AS $873.91 $239,451 D/D (274) 15,062 0 %
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2024-02-01 4 AS $945.61 $258,152 D/D (273) 14,789 0 %
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2024-02-05 4 S $934.71 $934,710 D/D (1,000) 13,789 0 %
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2024-03-01 4 AS $967.50 $346,365 D/D (358) 13,431 0 %
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2024-04-01 4 AS $964.73 $241,183 D/D (250) 13,181 0 %
REGN Regeneron Pharmaceuticals... EVP Commercial   •       –      –    2024-05-01 4 AS $889.41 $222,353 D/D (250) 12,931 0 %

  87  Records found
  1   2   3   4     
  Page 4 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed